The molecular pathogenesis of SOX2 in prostate cancer

被引：0
|
作者：
Liu, Shixue [1 ]
Yu, Honglian [2 ]
Zhao, Zhankui [3 ,4 ]
机构：
[1] Jining Med Univ, Jining 272067, Shandong, Peoples R China
[2] Jining Med Univ, Dept Biochem, 133 Hehua Rd, Jining 272067, Shandong, Peoples R China
[3] Jining Med Univ, Affiliated Hosp, Dept Urol, 89 Guhuai Rd, Jining 272029, Shandong, Peoples R China
[4] Shanghai Univ TCM, Peoples Hosp 7, Dept Urol, Shanghai 200137, Peoples R China
来源：
DISCOVER ONCOLOGY | 2025年 / 16卷 / 01期
关键词：
SOX2; Prostate cancer; Pathogenic mechanism; STEM-CELL; MESENCHYMAL TRANSITION; LINEAGE PLASTICITY; SIGNALING PATHWAY; METASTASIS; EXPRESSION; PROLIFERATION; AMPLIFICATION; RESISTANCE; INVASION;
D O I：
10.1007/s12672-025-01972-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SOX2 is one of the members of the SOX transcription factor family, which is believed to be an important transcription factor that plays a role in embryonic development, maintenance of stem cells, cancer progression, and resistance to cancer treatment. There is increasing evidence suggesting that SOX2 is crucial for the initiation, progression, invasion, metastasis, and treatment resistance of prostate cancer, therefore understanding the mechanism of SOX2 in prostate cancer can provide better targets for the treatment of prostate cancer. This article reviews the structural domains, normal physiological functions, and role in prostate cancer progression of SOX2, providing potential targets for prostate cancer treatment.
引用
收藏
页数：13
相关论文
共 50 条
  • [41] SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond
    Schaefer, Thorsten
    Lengerke, Claudia
    ONCOGENE, 2020, 39 (02) : 278 - 292
  • [42] SOX2 as a potential prognostic biomarker and molecular target in lung cancer: a meta-analysis
    Zang, K.
    Yu, Z. -H.
    Wang, M.
    Huang, Y.
    Zhu, X-X.
    Yao, B.
    REVISTA CLINICA ESPANOLA, 2022, 222 (10): : 584 - 592
  • [43] SOX2 as a prognostic marker and a potential molecular target in cervical cancer: A meta-analysis
    Yuan, Dandan
    Wang, Jian
    Yan, Mingyu
    Xu, Yaohui
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2021, 36 (04): : 45 - 53
  • [44] Generation of a biotinylatable Sox2 mouse model to identify Sox2 complexes in vivo
    Schilders, Kim
    Eenjes, Evelien
    Edel, Gabriela
    de Munck, Anne Boerema
    van Kempen, Marjon Buscop
    Demmers, Jeroen
    Wijnen, Rene
    Tibboel, Dick
    Rottier, Robbert J.
    TRANSGENIC RESEARCH, 2018, 27 (01) : 75 - 85
  • [45] Generation of a biotinylatable Sox2 mouse model to identify Sox2 complexes in vivo
    Kim Schilders
    Evelien Eenjes
    Gabriëla Edel
    Anne Boerema de Munck
    Marjon Buscop van Kempen
    Jeroen Demmers
    René Wijnen
    Dick Tibboel
    Robbert J. Rottier
    Transgenic Research, 2018, 27 : 75 - 85
  • [46] The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention
    Nelson, WG
    De Marzo, AM
    DeWeese, TL
    UROLOGY, 2001, 57 (4A) : 39 - 45
  • [47] SOX2 is required to maintain cancer stem cells in ovarian cancer
    Wen, Yiping
    Hou, Yaya
    Huang, Zaiju
    Cai, Jing
    Wang, Zehua
    CANCER SCIENCE, 2017, 108 (04) : 719 - 731
  • [48] AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation
    Zhen Wang
    Li Kang
    Huifang Zhang
    Yuanyong Huang
    Lan Fang
    Menghan Li
    Peter J. Brown
    Cheryl H. Arrowsmith
    Jiwen Li
    Jiemin Wong
    Oncogene, 2019, 38 : 5250 - 5264
  • [49] Molecular Pathogenesis and Progression of Prostate Cancer
    Schrecengost, Randy
    Knudsen, Karen E.
    SEMINARS IN ONCOLOGY, 2013, 40 (03) : 244 - 258
  • [50] The molecular pathogenesis of human prostate cancer
    Nelson, WG
    DeMarzo, AM
    DeWeese, TL
    Isaacs, WB
    HORMONAL CARCINOGENESIS IV, 2005, : 34 - 44
12345